BioCentra specializes in infectious disease diagnostics, emphasizing the importance of timely and accurate testing, particularly in the wake of the COVID-19 pandemic. The company offers a wide range of laboratory tests, including COVID-19 RT-PCR tests, rapid antigen tests, and antibody tests, all designed to be non-invasive, affordable, and convenient for consumers. Their services extend beyond COVID-19, providing wellness panels, allergy testing, and other infectious disease diagnostics. BioCentra partners with national laboratories to ensure high-quality testing services are accessible to patients, allowing them to order tests online and receive results securely via email within a few business days.

The company prides itself on its patient-centric approach, offering on-demand lab testing and health consultation services. BioCentra is a CLIA-accredited laboratory, which underscores its commitment to maintaining high standards in laboratory testing. Patients can easily select tests, make payments, and deposit samples at partner locations, with the added benefit of consultations with physicians to help determine the most appropriate tests. Since its establishment in 2019, BioCentra has served thousands of patients, particularly in the greater Houston area, focusing on providing accessible and efficient healthcare solutions.

United States

We develop novel and sustainable products and technologies in bio-therapeutics, vaccines and personalized diagnostics of cancer and infectious diseases. Most of the company's efforts have been directed toward in-house innovation in drug development and diagnostics; biotechnology consulting to pharmaceutical companies interested in technologies related to biosimilar and biologics development; and specialized contract research services to clinical and academic research institutions in order to design solutions based on novel methods and protocols useful in clinical validation of biopharmaceutical molecules and vaccines.

BioCentra

Company Details